One of the core missions of ELZA is to advance eyecare – rather than solely administer it. For us, this involves a considerable amount of research work, both pre-clinical (in the laboratory) and clinical. And it’s international conferences where this work is often presented for the first time to our peers in ophthalmology and visual science. Furthermore, we have world-leading surgeons and researchers amongst our ranks, who are also in great demand as lecturers and presenters at congresses and meetings.
From 12–15 September 2025, the ELZA team will be at the European Society of Cataract and Refractive Surgeons (ESCRS) Annual Meeting at the Bella Center, Copenhagen. Across multiple subspecialties, our clinicians and researchers will share work that not only advances science but also offers immediate clinical relevance.
Keratoconus and Corneal Cross-Linking
Prof. Farhad Hafezi, MD, PhD, FARVO will unveil progress from the 2nd Global Consensus on Keratoconus, shaping worldwide diagnostic and treatment standards. Dr. Dr. Emilio Torres-Netto, MD, PhD, FWCRS will address surgical considerations for cataract patients with keratoconus, while advanced cross-linking techniques such as ELZA-PACE, ECO-CAIRS, and PACK-CXL will be discussed for their transformative potential in ectasic cornea and infectious keratitis.
Glaucoma Innovation
Prof. Kaweh Mansouri MD, MPH will explore the future of glaucoma care, inviting delegates to engage with forward-looking treatment paradigms – from AI-guided diagnostics to endothelial-sparing surgical strategies.
Complex Corneal Surgery
PD Dr. Lamis Baydoun will present refinements in DMEK for challenging cases, offering pearls for expanding indications and improving surgical outcomes.
Why Attend ELZA’s Presentations?
ELZA’s programme reflects our role at the intersection of translational science and surgical innovation. Each session provides actionable insights for the clinic – whether it’s adopting a new surgical approach, refining diagnostics, or understanding the latest biomechanical research.
Friday, 12 September 2025
Time (CEST) | Title | Presenter | Location | Session | Why attend? |
---|---|---|---|---|---|
09:10 – 09:20 | Cataract surgery and keratoconus | Dr. Dr. Emilio Torres-Netto, MD, PhD, FWCRS | D1 | CD01 – Cataract Surgery in patients with cornea pathology | Gain practical pearls for tailoring cataract surgery to the biomechanical and refractive challenges of keratoconic corneas. |
10:00 – 10:05 | Intro and Poll: What will be the cornerstone of glaucoma management in 2050? | Prof. Dr. Kaweh Mansouri, MD, MPH | Auditorium 10 | GD03 – Innovation Session: Choose your Future | Participate in a forward-looking dialogue on emerging glaucoma treatments, from AI to advanced surgical techniques. |
12:50 – 13:00 | DMEK in challenging cases | PD Dr. Dr. Lamis Baydoun, MD, PhD | D1 | CD03 – Developments in Keratoplasty | Learn surgical adaptations that expand the use of DMEK in eyes with complex anterior segment anatomy. |
13:55 – 14:05 | Protecting the Endothelium: Strategies to Minimize Trauma in Glaucoma Management | Prof. Dr. Kaweh Mansouri, MD, MPH | Auditorium 10 | GD05 – The Eternal Battle: Cornea VS Glaucoma | Discover strategies to preserve corneal endothelial health when managing glaucoma surgically. |
16:00 – 16:08 | 2nd Global Consensus on keratoconus: Introduction | Prof. Dr. Farhad Hafezi, MD, PhD, FARVO | D1 | CD04 – New developments in keratoconus and crosslinking | Hear first-hand about the global consensus process that will influence keratoconus diagnosis and management worldwide. |
Saturday, 13 September 2025
Time (CEST) | Title | Presenter | Location | Session | Why attend? |
---|---|---|---|---|---|
09:10 – 09:15 | AI-powered CXL treatment planning – First clinical results | Dr. Dr. Emilio Torres-Netto, MD, PhD, FWCRS | D1 | CD06 – Corneal Crosslinking Advances | See how artificial intelligence is entering the clinical workflow to optimise CXL treatment planning. |
14:20 – 14:25 | ELZA-PACE: Customized topography-guided transepithelial CXL | Dr. Dr. Emilio Torres-Netto, MD, PhD, FWCRS | D1 | CD08 – Innovations in keratoconus management | Understand the benefits of a highly customised, tissue-preserving approach to epi-on CXL for keratoconus. |
15:05 – 15:15 | ECO-CAIRS: Extracorporeal corneal allogenic intrastromal ring segments | Dr. Shady Awwad, MD, PhD | D1 | CD08 – Innovations in keratoconus management | Learn about a novel modification of CAIRS using ultra-high-fluence cross-linking on donor segments before implantation. |
Sunday, 14 September 2025
Time (CEST) | Title | Presenter | Location | Session | Why attend? |
---|---|---|---|---|---|
08:30 – 08:35 | High-fluence accelerated CXL in advanced keratoconus | Dr. Dr. Emilio Torres-Netto, MD, PhD, FWCRS | D1 | CD12 – Clinical outcomes in CXL | Review the outcomes of high-fluence accelerated CXL in patients with advanced keratoconus. |
09:00 – 09:05 | PACK-CXL for infectious keratitis – Long-term results | Prof. Dr. Farhad Hafezi, MD, PhD, FARVO | D1 | CD12 – Clinical outcomes in CXL | See the extended follow-up results for PACK-CXL in treating infectious keratitis. |
14:50 – 14:55 | Advances in glaucoma diagnostics | Prof. Dr. Kaweh Mansouri, MD, MPH | Auditorium 10 | GD09 – Glaucoma Diagnostic Frontiers | Explore the latest advances in glaucoma diagnostics, from imaging to AI-based risk assessment. |
Monday, 15 September 2025
Time (CEST) | Title | Presenter | Location | Session | Why attend? |
---|---|---|---|---|---|
08:30 – 08:35 | Long-term outcomes of ELZA-sub400 protocol | Dr. Dr. Emilio Torres-Netto, MD, PhD, FWCRS | D1 | CD15 – Long-term CXL results | Assess five-year follow-up data on ELZA’s individualised protocol for ultra-thin keratoconic corneas. |
09:20 – 09:25 | Optimizing oxygen availability in epi-on CXL | Prof. Dr. Farhad Hafezi, MD, PhD, FARVO | D1 | CD15 – Long-term CXL results | Learn how optimising oxygen availability can enhance the efficacy of epi-on CXL protocols. |